Address: 216 Boulevard St. Germain
75007 Paris
,France
Tel: +33 1 53 63 88 77
Web: http://www.nordicpharmagroup.com/
The Nordic Group is a privately-owned, fast-growing, fully-integrated, pan-European Pharmaceutical Group with a strong emphasis on quality products and services that cater to the special needs of each client and patient.
The Nordic Group originated in 1995 with the establishment of the first Nordic organisation in Scandinavia. In the years that followed, the Nordic Group gradually expanded its geographical implantation throughout Europe and significantly enlarged its range of activities.
The French subsidiary is the group’s main source of revenues.
Today, the Nordic Group continues to capitalise on its existing platform of core competencies, products, services and technologies to develop the Company in two specialised segments of the Pharmaceutical market :
Marketing & Sales of Speciality pharmaceuticals
Specialised Pharmaceutical Services which focus on Product Development, Manufacturing, Supply Logistics and Regulatory activities.
Vincent Leonhardt explains how the French administration’s zeal for life science innovation can actually place pressure on some pharma SMEs. He also discusses the challenges he faced during his first…
Nordic Pharma has been established in the French market since 2002 as one of its first steps towards internationalization. What have been the main milestones and achievements of Nordic in…
Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France…
There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall?…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always have had the feelings…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the…
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different sectors? FEFIS represents as much as possible activities…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical companies developing products for the pharmaceutical sector. To what degree…
France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like? I have spent half…
See our Cookie Privacy Policy Here
